iTBS for Increased Appetite Induced by Antipsychotics

Recruiting N/A Interventional Study
Schizophrenia
No Placebo Group Every participant receives an active treatment — no one gets a placebo.
Ready to participate?

Review the details below, then apply to join this clinical trial.

At a Glance
Age
18 – 40
Sex
Any
Study type
Interventional
Purpose
Treatment
Participants needed
60 (estimated)
Sponsor
Central South University · Other
Think this trial could be right for you?

Answer a few quick questions to see if you may meet the eligibility requirements.

Check Your Eligibility
About This Trial
Antipsychotics are prone to cause metabolic side effects, including weight gain, hyperglycemia, insulin resistance, hyperlipidemia and so on, leading to a 2-3 times higher risk of death in patients with schizophrenia compared to healthy people. Conventional high-frequency rTMS have been used to treat people with obesity and showed certain effectiveness. However, studies involving schizophrenia pat…
Trial Locations
Loading…

Loading trial locations…

Eligibility Criteria
Inclusion Criteria: 1. Age between 18-40 years old; 2. Meeting the diagnostic criteria for schizophrenia in DSM-5 (Diagnostic and Statistical Manual of Mental Disorders, Fifth Edition); 3. BMI ≥ 25kg/m 2 or over 10% weight gain after taking antipsychotics in the last year; 4. Not receiving TMS ther…
Contacts

Renrong Wu, M.D. Ph.D

+8615874179855

wurenrong@csu.edu.cn

CONTACT

Jing Huang, M.D. Ph.D

15874290980

jinghuangserena@csu.edu.cn

CONTACT